Table 2: Treatment characteristics of the case group () treated with FCM.

Treatment characteristics

Hb at 1st FCM treatment, g/dL ()8.4 7.7; 8.9]
Hb at 1st FCM treatment, mmol/L ()5.2 4.8; 5.5]
MCV at 1st FCM treatment, fL ()69 62; 76]
Gestational age at 1st treatment, weeks ()34 + 6 32; 36 + 4]
Gestational age at 2nd treatment, weeks ()35 + 2 32 + 6; 37 + 3]
Gestational age at 3rd treatment, weeks ()32 N/E]
Total dose received, mg1000 1000; 1500]
Treatment-related adverse outcomes reported0 (0%)
Treatment-related serious adverse outcomes0 (0%)

Data shown as median IQR] or (%); patients with available data (for remainder of study population not reported); total number of patients receiving treatment; Hb: hemoglobin; MCV: mean corpuscular volume; IQR: interquartile range.